<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:b9ef6ba3-e582-4cec-b4d3-3d2d37d51c94,g:e31338a7-c0e6-469d-a959-928814ff1504,d:6329361740e847c1a4222628c54ab91f--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mgen-20201202</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl80L2ZyYWc6ZmFjZjJiMGYyZWUyNDNkNzg3YTY4MjlkY2IyYTQ4ZjIvdGFibGU6NmRkYzgxYjU2M2EwNDE5MGEyMDAxZDNmNDgwNDc2MjcvdGFibGVyYW5nZTo2ZGRjODFiNTYzYTA0MTkwYTIwMDFkM2Y0ODA0NzYyN18wLTEtMS0xLTA_1e8f008b-99ac-4d1e-b834-3d4ec54c7afe">false</ix:nonNumeric><ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl80L2ZyYWc6ZmFjZjJiMGYyZWUyNDNkNzg3YTY4MjlkY2IyYTQ4ZjIvdGFibGU6NmRkYzgxYjU2M2EwNDE5MGEyMDAxZDNmNDgwNDc2MjcvdGFibGVyYW5nZTo2ZGRjODFiNTYzYTA0MTkwYTIwMDFkM2Y0ODA0NzYyN180LTEtMS0xLTA_9f9c0c7b-3142-46f0-861c-c7e4d4cd5255">0001590750</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mgen-20201202.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ic423df897b244724ab35856337eeb9df_D20201202-20201202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001590750</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-02</xbrli:startDate><xbrli:endDate>2020-12-02</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i6329361740e847c1a4222628c54ab91f_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGV4dHJlZ2lvbjplNmYwNThjYjVhMzM0NzNjYTA0MGIwN2NhYzkzZDQ3Ml81NTkz_f705a404-e02d-4882-8007-85ad6c2de1dd">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">of the Securities Exchange Act of 1934</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): December&#160;4, 2020 (<ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGV4dHJlZ2lvbjplNmYwNThjYjVhMzM0NzNjYTA0MGIwN2NhYzkzZDQ3Ml8yNDI_5f2f0e85-e4ae-4241-a26b-371efa4e2043">December 2, 2020</ix:nonNumeric>)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="mgen-20201202_g1.jpg" alt="mgen-20201202_g1.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:121px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGV4dHJlZ2lvbjplNmYwNThjYjVhMzM0NzNjYTA0MGIwN2NhYzkzZDQ3Ml81NTg5_3cbdb3d9-ced9-4f45-a996-0f282114be83">MIRAGEN THERAPEUTICS, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.451%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.452%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGFibGU6NTE1MDZiNmM3OGUzNDU0ZGJiNjU5OWE4ZDNjNTA0MWQvdGFibGVyYW5nZTo1MTUwNmI2Yzc4ZTM0NTRkYmI2NTk5YThkM2M1MDQxZF8wLTAtMS0xLTA_c8f9f7f4-42b3-4675-b36e-867d2039e55c">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGFibGU6NTE1MDZiNmM3OGUzNDU0ZGJiNjU5OWE4ZDNjNTA0MWQvdGFibGVyYW5nZTo1MTUwNmI2Yzc4ZTM0NTRkYmI2NTk5YThkM2M1MDQxZF8wLTItMS0xLTA_94b9229a-4a84-434b-aaaf-5f7932ee9501">001-36483</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGFibGU6NTE1MDZiNmM3OGUzNDU0ZGJiNjU5OWE4ZDNjNTA0MWQvdGFibGVyYW5nZTo1MTUwNmI2Yzc4ZTM0NTRkYmI2NTk5YThkM2M1MDQxZF8wLTQtMS0xLTA_4262dd0c-657c-463f-9781-70ec89d4ad50">47-1187261</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">of incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer</span></div><div style="margin-bottom:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Identification No.)</span></div></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.239%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:21.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.095%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.106%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.707%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGFibGU6ZDU0Y2M2NjE2OWI0NDQzYjg5YTIwOTI2MjBjMDg3ZDQvdGFibGVyYW5nZTpkNTRjYzY2MTY5YjQ0NDNiODlhMjA5MjYyMGMwODdkNF8wLTEtMS0xLTA_02b5d772-7930-4673-b64f-c85d7913706a">6200 Lookout Rd.</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGFibGU6ZDU0Y2M2NjE2OWI0NDQzYjg5YTIwOTI2MjBjMDg3ZDQvdGFibGVyYW5nZTpkNTRjYzY2MTY5YjQ0NDNiODlhMjA5MjYyMGMwODdkNF8xLTEtMS0xLTA_4938937e-e11f-4add-869c-420782b420ab">Boulder</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;<ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGFibGU6ZDU0Y2M2NjE2OWI0NDQzYjg5YTIwOTI2MjBjMDg3ZDQvdGFibGVyYW5nZTpkNTRjYzY2MTY5YjQ0NDNiODlhMjA5MjYyMGMwODdkNF8xLTItMS0xLTA_98125234-f2b9-4c34-8ebd-73a808fb1ff1">CO</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGFibGU6ZDU0Y2M2NjE2OWI0NDQzYjg5YTIwOTI2MjBjMDg3ZDQvdGFibGVyYW5nZTpkNTRjYzY2MTY5YjQ0NDNiODlhMjA5MjYyMGMwODdkNF8xLTUtMS0xLTA_7ccacb86-6edf-44ec-9a6a-c2405ba0ff5b">80301</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGV4dHJlZ2lvbjplNmYwNThjYjVhMzM0NzNjYTA0MGIwN2NhYzkzZDQ3Ml81NTkw_e80bd20c-f282-4f6c-b1d5-29c0360e3782">720</ix:nonNumeric>) <ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGV4dHJlZ2lvbjplNmYwNThjYjVhMzM0NzNjYTA0MGIwN2NhYzkzZDQ3Ml81NTkx_142d93ef-864f-44a7-aee6-619a9d6d0b80">643-5200</ix:nonNumeric>&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report) </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions: </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:2.125%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.675%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGFibGU6OWJkMzJmODcyZmEwNDJhNjk1OGQ5YzhkNzQwOWIwNTEvdGFibGVyYW5nZTo5YmQzMmY4NzJmYTA0MmE2OTU4ZDljOGQ3NDA5YjA1MV8wLTAtMS0xLTA_aa7b2c7d-8b68-44a4-bc5f-47c38e93ce82">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGFibGU6OWJkMzJmODcyZmEwNDJhNjk1OGQ5YzhkNzQwOWIwNTEvdGFibGVyYW5nZTo5YmQzMmY4NzJmYTA0MmE2OTU4ZDljOGQ3NDA5YjA1MV8xLTAtMS0xLTA_3777d27d-6244-4933-a1e9-1b254ca27f5d">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGFibGU6OWJkMzJmODcyZmEwNDJhNjk1OGQ5YzhkNzQwOWIwNTEvdGFibGVyYW5nZTo5YmQzMmY4NzJmYTA0MmE2OTU4ZDljOGQ3NDA5YjA1MV8yLTAtMS0xLTA_c410d4d9-833a-43bb-9b87-392617a4fc71">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGFibGU6OWJkMzJmODcyZmEwNDJhNjk1OGQ5YzhkNzQwOWIwNTEvdGFibGVyYW5nZTo5YmQzMmY4NzJmYTA0MmE2OTU4ZDljOGQ3NDA5YjA1MV8zLTAtMS0xLTA_ebd9a1f5-9a52-4e8e-99cb-8b2739f515b1">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.889%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGFibGU6ZWVhMjBmNWNkZTg1NGU5NWFiYzM4OTY2OGUzZjFkZDQvdGFibGVyYW5nZTplZWEyMGY1Y2RlODU0ZTk1YWJjMzg5NjY4ZTNmMWRkNF8xLTAtMS0xLTA_d6056d41-2533-4a7f-8b98-19c7ddd13970">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGFibGU6ZWVhMjBmNWNkZTg1NGU5NWFiYzM4OTY2OGUzZjFkZDQvdGFibGVyYW5nZTplZWEyMGY1Y2RlODU0ZTk1YWJjMzg5NjY4ZTNmMWRkNF8xLTMtMS0xLTA_0c0ba651-2c39-4a70-a117-1c781df25470">MGEN</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGFibGU6ZWVhMjBmNWNkZTg1NGU5NWFiYzM4OTY2OGUzZjFkZDQvdGFibGVyYW5nZTplZWEyMGY1Y2RlODU0ZTk1YWJjMzg5NjY4ZTNmMWRkNF8xLTUtMS0xLTA_48490bd5-4e97-4b11-b47a-21d65e87e1f4">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter). </span></div><div style="margin-top:10pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic423df897b244724ab35856337eeb9df_D20201202-20201202" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjYzMjkzNjE3NDBlODQ3YzFhNDIyMjYyOGM1NGFiOTFmL3NlYzo2MzI5MzYxNzQwZTg0N2MxYTQyMjI2MjhjNTRhYjkxZl8xL2ZyYWc6ZTZmMDU4Y2I1YTMzNDczY2EwNDBiMDdjYWM5M2Q0NzIvdGV4dHJlZ2lvbjplNmYwNThjYjVhMzM0NzNjYTA0MGIwN2NhYzkzZDQ3Ml81NTky_b1504966-0ae5-43b7-a9ba-02cc983978aa">&#9744;</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 2, 2020, Diana Escolar, M.D., FAAN, provided notice of her intention to resign as the Chief Medical Officer of Miragen Therapeutics, Inc., a Delaware corporation (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), effective as of January 1, 2021. In connection with her resignation, the Company anticipates entering into a separation agreement with Dr. Escolar, (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separation Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) pursuant to which Dr. Escolar would receive the following severance benefits: (i) payment of 12 months of Dr. Escolar&#8217;s current base salary, subject to standard payroll deductions and withholdings, and to be made on the Company&#8217;s ordinary payroll dates following her separation from the Company, (ii) accelerated vesting of all currently unvested and outstanding stock options previously awarded to Dr. Escolar, and (iii) payment of Dr. Escolar&#8217;s COBRA premiums for the period starting on her separation from the Company and ending on the earliest to occur of (x) 12 months following the separation date; (y) the date Dr. Escolar becomes eligible for substantially equivalent group health insurance coverage through a new employer; or (z) the date Dr. Escolar ceases to be eligible for COBRA continuation coverage for any reason, including plan termination.  The payment of the foregoing benefits under the Separation Agreement are conditioned upon the effectiveness of a general release in favor of the Company. Additionally, Dr. Escolar will be entitled to receive 100% of her target bonus for 2020 (which is equal to $166,000) as and when such bonuses are paid in 2021.</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*          *          *</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:44.941%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.178%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.973%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.235%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Miragen Therapeutics, Inc.</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: December 4, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jason A. Leverone</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jason A. Leverone</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer, Treasurer , and Secretary</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "mgen-20201202.htm", "description": "8-K", "secsgml_size_bytes": 35585}]
{"company-data": {"conformed-name": "MIRAGEN THERAPEUTICS, INC.", "cik": "0001590750", "assigned-sic": "8071", "irs-number": "471187261", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-36483", "film-number": "201370302"}, "business-address": {"street1": "6200 LOOKOUT ROAD", "city": "BOULDER", "state": "CO", "zip": "80301", "phone": "303-531-5952"}, "mail-address": {"street1": "6200 LOOKOUT ROAD", "city": "BOULDER", "state": "CO", "zip": "80301"}, "former-company": [{"former-conformed-name": "MIRAGEN THERAPEUTICS, INC.", "date-changed": "20170213"}, {"former-conformed-name": "SIGNAL GENETICS, INC.", "date-changed": "20140710"}, {"former-conformed-name": "SIGNAL GENETICS LLC", "date-changed": "20131031"}]}
mgen-20201202
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 4, 2020 (
December 2, 2020
)
MIRAGEN THERAPEUTICS, INC.
(Exact name of registrant as specified in its charter)
Delaware
001-36483
47-1187261
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
6200 Lookout Rd.
Boulder
CO
80301
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code: (
720
)
643-5200
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.01 par value
MGEN
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 2, 2020, Diana Escolar, M.D., FAAN, provided notice of her intention to resign as the Chief Medical Officer of Miragen Therapeutics, Inc., a Delaware corporation (the "
Company
"), effective as of January 1, 2021. In connection with her resignation, the Company anticipates entering into a separation agreement with Dr. Escolar, (the "
Separation Agreement
") pursuant to which Dr. Escolar would receive the following severance benefits: (i) payment of 12 months of Dr. Escolar's current base salary, subject to standard payroll deductions and withholdings, and to be made on the Company's ordinary payroll dates following her separation from the Company, (ii) accelerated vesting of all currently unvested and outstanding stock options previously awarded to Dr. Escolar, and (iii) payment of Dr. Escolar's COBRA premiums for the period starting on her separation from the Company and ending on the earliest to occur of (x) 12 months following the separation date; (y) the date Dr. Escolar becomes eligible for substantially equivalent group health insurance coverage through a new employer; or (z) the date Dr. Escolar ceases to be eligible for COBRA continuation coverage for any reason, including plan termination.  The payment of the foregoing benefits under the Separation Agreement are conditioned upon the effectiveness of a general release in favor of the Company. Additionally, Dr. Escolar will be entitled to receive 100% of her target bonus for 2020 (which is equal to $166,000) as and when such bonuses are paid in 2021.
*          *          *
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Miragen Therapeutics, Inc.
Date: December 4, 2020
By:
/s/ Jason A. Leverone
Jason A. Leverone
Chief Financial Officer, Treasurer , and Secretary